All Stories

  1. S1PR3-driven positive feedback loop sustains STAT3 activation and keratinocyte hyperproliferation in psoriasis
  2. Inhibition of KPNA2 by ivermectin reduces E2F1 nuclear translocation to attenuate keratinocyte proliferation and ameliorate psoriasis-like lesions
  3. Reprogramming of the LXRα Transcriptome Sustains Macrophage Secondary Inflammatory Responses
  4. Transcriptional determinants of lipid mobilization in human adipocytes
  5. A Comprehensive Review of Animal Models for Cancer Cachexia: Implications for Translational Research
  6. Antioxidants stimulate BACH1-dependent tumor angiogenesis
  7. γ-Linolenic acid in maternal milk drives cardiac metabolic maturation
  8. Editorial: Functional epigenetic regulation in metabolic diseases
  9. Antagonistic action of GPS2 and KDM1A at enhancers governs alternative macrophage activation by interleukin 4
  10. Estrogen Receptor β (ESR2) Transcriptome and Chromatin Binding in a Mantle Cell Lymphoma Tumor Model Reveal the Tumor-Suppressing Mechanisms of Estrogens
  11. An optimized 4C-seq protocol based on cistrome and epigenome data in the mouse RAW264.7 macrophage cell line
  12. Plaque Evaluation by Ultrasound and Transcriptomics Reveals BCLAF1 as a Regulator of Smooth Muscle Cell Lipid Transdifferentiation in Atherosclerosis
  13. The corepressors GPS2 and SMRT control enhancer and silencer remodeling via eRNA transcription during inflammatory activation of macrophages
  14. Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα
  15. G protein pathway suppressor 2 (GPS2) links inflammation and cholesterol efflux by controlling lipopolysaccharide-induced ATP-binding cassette transporter A1 expression in macrophages
  16. GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation
  17. Transcriptional repression in macrophages-basic mechanisms and alterations in metabolic inflammatory diseases
  18. Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes
  19. Development and application of a blocking enzyme-linked immunosorbent assay (ELISA) to differentiate antibodies against live and inactivated porcine reproductive and respiratory syndrome virus